Christina G Kwong1, Leonard B Bacharier2. 1. Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis Children's Hospital, One Children's Place, St. Louis, MO, 63110, USA. 2. Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis Children's Hospital, One Children's Place, St. Louis, MO, 63110, USA. bacharier_L@wustl.edu.
Abstract
PURPOSE OF REVIEW: Antibiotics are commonly used to treat wheezy lower respiratory tract illnesses in preschoolers, although these infections have been traditionally thought to be predominantly of viral origin. Our purpose is to review recent research pertaining to the role of antibiotics in lower respiratory tract illnesses and on subsequent asthma development, as well as the possible mechanisms of their effects. RECENT FINDINGS: Increasing evidence suggests that asthma pathogenesis is associated with events during infancy and early childhood, particularly respiratory tract infections. While viruses are frequently detected in children with lower respiratory tract infections, the presence of potentially pathogenic bacteria is also often detected and may play a role in asthma pathogenesis. Recent evidence suggests that use of macrolides, particularly azithromycin, may decrease the risk of and duration of lower respiratory tract illnesses and prevent future episodes in specific high-risk populations. Infants and preschoolers who have wheezy lower respiratory tract illnesses have a higher risk of asthma development. Alterations in the microbiome are thought to be influential. While several recent studies identify azithromycin as a therapeutic option in these illnesses, additional research is needed.
PURPOSE OF REVIEW: Antibiotics are commonly used to treat wheezy lower respiratory tract illnesses in preschoolers, although these infections have been traditionally thought to be predominantly of viral origin. Our purpose is to review recent research pertaining to the role of antibiotics in lower respiratory tract illnesses and on subsequent asthma development, as well as the possible mechanisms of their effects. RECENT FINDINGS: Increasing evidence suggests that asthma pathogenesis is associated with events during infancy and early childhood, particularly respiratory tract infections. While viruses are frequently detected in children with lower respiratory tract infections, the presence of potentially pathogenic bacteria is also often detected and may play a role in asthma pathogenesis. Recent evidence suggests that use of macrolides, particularly azithromycin, may decrease the risk of and duration of lower respiratory tract illnesses and prevent future episodes in specific high-risk populations. Infants and preschoolers who have wheezy lower respiratory tract illnesses have a higher risk of asthma development. Alterations in the microbiome are thought to be influential. While several recent studies identify azithromycin as a therapeutic option in these illnesses, additional research is needed.
Authors: Leonardo A Pinto; Paulo M Pitrez; Fernanda Luisi; Patricia Piccoli de Mello; Moisés Gerhardt; Roberta Ferlini; Daniel Cardoso Barbosa; Ivana Daros; Marcus H Jones; Renato T Stein; Paulo J Marostica Journal: J Pediatr Date: 2012-06-28 Impact factor: 4.406
Authors: Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: Markus J Ege; Melanie Mayer; Anne-Cécile Normand; Jon Genuneit; William O C M Cookson; Charlotte Braun-Fahrländer; Dick Heederik; Renaud Piarroux; Erika von Mutius Journal: N Engl J Med Date: 2011-02-24 Impact factor: 91.245
Authors: Susan V Lynch; Robert A Wood; Homer Boushey; Leonard B Bacharier; Gordon R Bloomberg; Meyer Kattan; George T O'Connor; Megan T Sandel; Agustin Calatroni; Elizabeth Matsui; Christine C Johnson; Henry Lynn; Cynthia M Visness; Katy F Jaffee; Peter J Gergen; Diane R Gold; Rosalind J Wright; Kei Fujimura; Marcus Rauch; William W Busse; James E Gern Journal: J Allergy Clin Immunol Date: 2014-06-04 Impact factor: 10.793
Authors: Avraham Beigelman; Megan Isaacson-Schmid; Geneline Sajol; Jack Baty; Oscar M Rodriguez; Erin Leege; Kevin Lyons; Toni L Schweiger; Jie Zheng; Kenneth B Schechtman; Mario Castro; Leonard B Bacharier Journal: J Allergy Clin Immunol Date: 2014-11-18 Impact factor: 10.793
Authors: R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez Journal: Lancet Date: 1999-08-14 Impact factor: 79.321
Authors: Dara G Torgerson; Tusar Giri; Todd E Druley; Jie Zheng; Scott Huntsman; Max A Seibold; Andrew L Young; Toni Schweiger; Huiqing Yin-Declue; Geneline D Sajol; Kenneth B Schechtman; Ryan D Hernandez; Adrienne G Randolph; Leonard B Bacharier; Mario Castro Journal: PLoS One Date: 2015-11-20 Impact factor: 3.240
Authors: Jakob Stokholm; Bo L Chawes; Nadja H Vissing; Elín Bjarnadóttir; Tine M Pedersen; Rebecca K Vinding; Ann-Marie M Schoos; Helene M Wolsk; Sunna Thorsteinsdóttir; Henrik W Hallas; Lambang Arianto; Susanne Schjørring; Karen A Krogfelt; Thea K Fischer; Christian B Pipper; Klaus Bønnelykke; Hans Bisgaard Journal: Lancet Respir Med Date: 2015-12-17 Impact factor: 30.700
Authors: Carolina Sanchez Aranda; Gustavo Falbo Wandalsen; Ana Caroline Cavalcanti Dela Bianca; Ellen de Oliveira Dantas; Javier Mallol; Dirceu Solé Journal: Rev Paul Pediatr Date: 2018 Oct-Dec